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TORCH is an acronym for Toxoplasma gondii (Toxo), other microorganisms (like 
syphilis), rubella (RV), cytomegalovirus (CMV), and herpesviruses  (HSV) that are 
associated with congenital abnormalities during maternal infection.  Prenatal testing for 
antibodies against these agents is one tool for prevention.  Automated random access 
analyzers like the IMMULITE 2000 are useful for TORCH testing.  We evaluated 
linearity, imprecision, and comparison to other commercially available methods of six 
IMMULITE 2000 TORCH assays including Toxo IgG, Toxo IgM, RV IgG, RV IgM, 
CMV IgG, and HSV IgG.  Toxo IgG and RV IgG, reported in IU/mL, were linear over 
acceptable ranges.  Toxo IgM, RV IgM, CMV IgG, and HSV IgG, reported as a signal to 
cutoff index (S/CO), were linear over acceptable ranges.  Total CV’s for negative 
controls or negative patient pools for Toxo IgG, Toxo IgM, RV IgG, RV IgM, CMV IgG, 
and HSV IgG ranged from 13.0-13.5%, 7.1-11.2%, 14.6-22.9%, 7.3-10.8 %, 13.0-19.5%, 
and 19.2-22.7%, respectively.  Total CV’s for positive controls or positive patient pools 
ranged from 4.8-6.0%, 4.4-8.0%, 4.9-9.0%, 4.7-6.4%, 2.5-12.2%, and 4.8-6.9% for Toxo 
IgG, Toxo IgM, RV IgG, RV IgM, CMV IgG, and HSV IgG, respectively.  Results of 
comparisons of the IMMULITE 2000 assays with other commercial assays are shown 
(Table 1).  Samples with equivocal results were excluded from evaluation.  Samples were 
tested for Toxo IgM by the Access, IMMULITE 2000, Platelia, and Vidas methods.  A 
consensus result required agreement by three of these four.  The IMMULITE 2000 RV 
IgM showed better concordance with the Zeus (referee) method than it did with the 
Diamedix method.  The IMMULITE 2000 TORCH assays show acceptable performance 
and are suitable for routine detection of Toxo IgG, Toxo IgM, RV IgG, RV IgM, CMV 
IgG, and HSV IgG.  It is noteworthy that some commercial assays for Toxo IgM and RV 
IgM show rather poor concordance. 
 
 
 Table 1          
TORCH Assay Agreement         
  Access Access Seraquest Seraquest Access Consensus Diamedix Zeus 
  Toxo IgG RV IgG CMV IgG HSV IgG Toxo IgM Toxo IgM RV IgM RV IgM 
IMMULITE 2000  Neg    Pos  Neg    Pos Neg    Pos  Neg    Pos  Neg    Pos  Neg    Pos   Neg    Pos  Neg     Pos 
              Number Neg    91         0     24         0  47          3    27        0  104      25  116        4   32       29   59        0 
              Number Pos   1          36   1        94   2          66   1         79   1         10   1           8    0         4    1         4 
                  
 Concordance (%) 99.2 99.2 95.8 99.1 81.4 96.1 55.4 98.4 
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